Linked perfusion to continuous-flow stirred-tank reactor cell culture system

US11104875B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11104875-B2
Application numberUS-201716071941-A
CountryUS
Kind codeB2
Filing dateJan 25, 2017
Priority dateJan 26, 2016
Publication dateAug 31, 2021
Grant dateAug 31, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods of protein production in a linked culture and production bioreactor system are provided. Such methods include a culture bioreactor (N-1 bioreactor) linked to production bioreactor (N bioreactor). More specifically, the methods include (a) culturing cells with a gene that encodes the protein of interest in a continuous perfusion culture bioreactor (N-1 bioreactor); inoculating a continuously stirred tank reactor (CSTR) production bioreactor (N bioreactor) with cells obtained from step (a); and culturing the cells in the CSTR production bioreactor under conditions that allow production of the protein of interest.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a protein of interest, comprising: (a) culturing cells comprising a gene that encodes the protein of interest in a culture bioreactor (N-1 bioreactor); (b) inoculating a production bioreactor (N bioreactor) with cells obtained from step (a); and (c) culturing the cells in the production bioreactor under conditions that allow production of the protein of interest, wherein the inoculation in step (b) is by transferring cells from the culture bioreactor to the production bioreactor, wherein the cell transfer is by cell bleed in semi-continuous mode comprising the cell transfer once at every period of time from 2 minutes to 24 hours or any interval there between. 2. The method according to claim 1 , wherein the method further comprises step (d) harvesting the protein of interest from the production bioreactor. 3. The method according to claim 1 , wherein the culture bioreactor is a continuous perfusion culture bioreactor and the production bioreactor is a continuously stirred tank reactor (CSTR) production bioreactor. 4. The method according to claim 1 , wherein the production bioreactor has no cell retention device. 5. The method according to claim 1 , wherein volume ratio of the culture bioreactor to the production bioreactor is about 1:1 to about 1:20. 6. The method according to claim 1 , wherein step (a) alternates between a first and second culture bioreactors to allow for renewal and continuous production of culture cells for use in step (b). 7. The method according to claim 6 , wherein the second culture bioreactor is a continuous perfusion culture bioreactor. 8. The method according to claim 1 , wherein the production bioreactor operates continuously for a period of greater than 3 weeks. 9. The method according to claim 2 , wherein harvesting step (d) is continuous. 10. The method according to claim 1 , wherein the cells are C.H.O. cells, HEK-293 cells, VERO cells, N.S.O. cells, PER.C6 cells, Sp2/0 cells, B.H.K. cells, MDCK cells, MDBK cells or C.O.S. cells. 11. The method according to claim 1 , wherein the production bioreactor has a volumetric productivity of at least 0.6 grams per liter per day for a period of at least 14 days. 12. The method according to claim 1 , wherein the production bioreactor has a product residence time of about 1 to about 10 days. 13. The method according to claim 1 , wherein the production bioreactor has a dilution rate of about 1 to about 0.1 volume per day. 14. The method according to claim 1 , wherein volume ratio of the culture bioreactor to the production bioreactor is about 1:5. 15. The method according to claim 1 , wherein the production bioreactor operates continuously for a period of greater than 4 weeks. 16. The method according to claim 1 , wherein the production bioreactor operates continuously for a period of greater than 5 weeks. 17. The method according to claim 1 , wherein the production bioreactor operates continuously for a period of greater than 6 weeks. 18. The method according to claim 1 , wherein the production bioreactor has a volumetric productivity of at least 0.6 grams per liter per day for a period of at least 20 days. 19. The method according to claim 1 , wherein the production bioreactor has a volumetric productivity of at least 0.6 grams per liter per day for a period of at least 30 days.

Assignees

Inventors

Classifications

  • Stirrer or mobile mixing elements · CPC title

  • Cells for production · CPC title

  • Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title

  • Culture media for cell or tissue culture (media for specific animal cell type C12N5/06) · CPC title

  • Perfusion · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11104875B2 cover?
Methods of protein production in a linked culture and production bioreactor system are provided. Such methods include a culture bioreactor (N-1 bioreactor) linked to production bioreactor (N bioreactor). More specifically, the methods include (a) culturing cells with a gene that encodes the protein of interest in a continuous perfusion culture bioreactor (N-1 bioreactor); inoculating a continuo…
Who is the assignee on this patent?
Boehringer Ingelheim Int, Hiller Gregory Walter, Gagnon Matthew Paul, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12M23/58. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).